US 11,897,892 B2
Substituted pyridotriazine compounds and uses thereof
Hang Chu, San Mateo, CA (US); Ana Z. Gonzalez Buenrostro, San Mateo, CA (US); Hongyan Guo, San Mateo, CA (US); Xiaochun Han, San Jose, CA (US); Anna E. Hurtley, San Mateo, CA (US); Lan Jiang, Foster City, CA (US); Jiayao Li, Foster City, CA (US); David W. Lin, Berkeley, CA (US); Michael L. Mitchell, Castro Valley, CA (US); Devan Naduthambi, San Bruno, CA (US); Gregg M. Schwarzwalder, Redwood City, CA (US); Suzanne M. Szewczyk, San Mateo, CA (US); Matthew J. Von Bargen, Redwood City, CA (US); Qiaoyin Wu, Foster City, CA (US); Hong Yang, Fremont, CA (US); and Jennifer R. Zhang, Union City, CA (US)
Assigned to Gilead Sciences, Inc., Foster City, CA (US)
Filed by Gilead Sciences, Inc., Foster City, CA (US)
Filed on Feb. 3, 2023, as Appl. No. 18/164,317.
Application 18/164,317 is a continuation of application No. 17/578,020, filed on Jan. 18, 2022, granted, now 11,613,546.
Claims priority of provisional application 63/190,461, filed on May 19, 2021.
Claims priority of provisional application 63/139,237, filed on Jan. 19, 2021.
Prior Publication US 2023/0257389 A1, Aug. 17, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 487/18 (2006.01); A61P 31/18 (2006.01); C07D 487/22 (2006.01); C07D 491/22 (2006.01)
CPC C07D 487/18 (2013.01) [A61P 31/18 (2018.01); C07D 487/22 (2013.01); C07D 491/22 (2013.01)] 35 Claims
 
1. A compound selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.